MICROBOT MEDICAL ($MBOT) is expected to release its quarterly earnings data on Tuesday, March 25th after market close, per Finnhub. Analysts are expecting revenue of ...
Microbot Medical is transitioning from R&D to commercialization with its LIBERTY single-use robotic system for endovascular interventions. I assign MBOT a neutral rating with a 1-year price target of ...
Microbot Medical (NASDAQ:MBOT) just reported results for the second quarter of 2024. Microbot Medical reported earnings per share of -17 cents. This met the analyst estimate for EPS of -17 cents. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results